24小时热门版块排行榜    

查看: 385  |  回复: 20
当前主题已经存档。
【悬赏金币】回答本帖问题,作者chendiqing将赠送您 30 个金币

zhgyg

铁杆木虫 (正式写手)

7.

[ Last edited by zhgyg on 2008-6-16 at 22:41 ]
11楼2008-06-16 22:32:23
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

fjxin2002

木虫 (正式写手)

★ ★ ★ ★ ★
chendiqing(金币+5,VIP+0):呵呵~~~
8.Lanthanide Triflate Catalyzed Biginelli Reaction. One-Pot Synthesis of Dihydropyrimidinones under Solvent-Free Conditions
Ma, Y.; Qian, C.; Wang, L.; Yang, M.
J. Org. Chem.; (Note); 2000; 65(12); 3864-3868.

[ Last edited by fjxin2002 on 2008-6-16 at 22:34 ]
12楼2008-06-16 22:33:02
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

zhgyg

铁杆木虫 (正式写手)

3.Pharmacologic profile of the dihydropyrimidine calcium channel blockers SQ 32,547 and SQ 32,926 [correction of SQ 32,946].Grover GJ, Dzwonczyk S, McMullen DM, Normandin DE, Parham CS, Sleph PG, Moreland S.
Department of Pharmacology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543, USA.

SQ 32,926 and SQ 32,547, two dihydropyrimidine calcium channel blockers, were characterized as potent inhibitors of depolarization-induced contractions of isolated smooth muscle preparations. In rat aorta, the IC50 values were 5.5 nM for SQ 32,547 and 8.1 nM for SQ 32,926, values which compare favorably with that of 2.9 nM for nifedipine. The dihydropyrimidines were also tested in a model of stable angina: pacing-induced ischemia in dogs. Both SQ 32,547 and SQ 32,926 reduced the ST-segment elevation observed in vehicle-treated animals. No significant changes in hemodynamic status were detected, suggesting that a reduction in cardiac work secondary to afterload reduction was probably not a major contributor to the protective effects. Neither was increased coronary blood flow important for the antiischemic outcome because no significant effects of the dihydropyrimidines were observed on ischemic regional blood flow. SQ 32,547 was also studied in globally ischemic, isolated rat hearts. In this model, SQ 32,547 was protective because it significantly reduced contracture formation and lactate dehydrogenase (LDH) release. Washing out the effect of SQ 32,547 in isolated hearts and smooth muscles was difficult, presumably due to its lipophilicity. In the smooth muscle preparations, the effects of both nifedipine and SQ 32,926 were much more easily washed out. As with other calcium channel blockers, increasing the antiischemic effects of SQ 32,547 was associated with a higher cost in terms of cardiac function. In summary, the two novel dihydropyrimidines, SQ 32,547 and SQ 32,926 showed antiischemic properties in animal models.

PMID: 7475054 [PubMed - indexed for MEDLINE]
13楼2008-06-16 22:38:08
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

fjxin2002

木虫 (正式写手)

★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
chendiqing(金币+15,VIP+0):恩,确实是的~~~~
第七个查到了,比较难找。Design and synthesis of novel α1a adrenoceptor-selective antagonists L structure-activity relationship in dihydropyrimidinones     《Journal of Medicinal Chemistry》  Barrow J C Selnick H C Selnick H C   2000 / 43 / P 2703-2705
14楼2008-06-16 22:38:11
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

zhgyg

铁杆木虫 (正式写手)

★ ★ ★ ★ ★
chendiqing(金币+5,VIP+0):呵呵~~~~
4.Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1, 2, 3, 4-tetrahydro-6-methyl-5

文献全文下载地址:http://pubs.acs.org/cgi-bin/abst ... 8.pdf?sessid=6006l3


比较难下,题目很长,你自己下下了打上把

[ Last edited by zhgyg on 2008-6-16 at 22:49 ]
15楼2008-06-16 22:47:45
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

fjxin2002

木虫 (正式写手)

4. Dihydropyrimidine calcium channel blockers:3-carbamoyl-4-aryl-1 2 3 4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effecitive antihypertensive agent     《Journal of Medicinal Chemistry》  Atwal K S Unger S E Unger S E   1991 / 34 / P 806
16楼2008-06-16 22:50:17
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

zhgyg

铁杆木虫 (正式写手)

详细的4:hydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents.Atwal KS, Swanson BN, Unger SE, Floyd DM, Moreland S, Hedberg A, O'Reilly BC.
Squibb Institute for Medical Research, Princeton, New Jersey 08543-4000.

In order to explain the potent antihypertensive activity of the modestly active (IC50 = 3.2 microM) dihydropyrimidine calcium channel blocker 5, we carried out drug metabolism studies in the rat and found 5 is metabolized to compounds 6-10. Two of the metabolites, 6 (IC50 = 16 nM) and 7 (IC50 = 12 nM), were found to be responsible for the antihypertensive activity of compound 5. Potential metabolism of 6 into 7 in vivo precluded our interest in pursuing compounds related to 6. Structure-activity studies aimed at identifying additional aryl-substituted analogues of 7 led to 17g,j,p with comparable potential in vivo, though these compounds were less potent than 7 in vitro. To investigate the effects of absolute stereochemistry on potency, we resolved 7 via diastereomeric ureas 19a,b, prepared from 18 by treatment with (R)-alpha-methylbenzylamine. Our results demonstrate that the active R-(-)-enantiomer 20a of 7 is both more potent and longer acting than nifedipine (1) as an antihypertensive agent in the SHR. The in vivo potency and duration of 20a is comparable to the long-acting dihydropyridine amlodipine. The superior oral antihypertensive activity of 20a compared to that of previously described carbamates 2 (R2 = COOEt) could be explained by its improved oral bioavailability, possibly resulting from increased stability of the urea functionality.

PMID: 1995904 [PubMed - indexed for MEDLINE]
17楼2008-06-16 22:50:18
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

zhgyg

铁杆木虫 (正式写手)

还有金币啊,我还想要
18楼2008-06-16 22:53:10
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

zbcheng163

木虫 (正式写手)

8:Lanthanide triflate catalyzed Biginelli reaction. one-pot synthesis of dihydropyrimidinones under
19楼2008-06-16 23:09:39
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 chendiqing 的主题更新
不应助 确定回帖应助 (注意:应助才可能被奖励,但不允许灌水,必须填写15个字符以上)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[考研] 346求调剂[0856] +4 WayneLim327 2026-03-16 7/350 2026-03-21 04:02 by JourneyLucky
[考研] 一志愿重庆大学085700资源与环境专硕,总分308求调剂 +3 墨墨漠 2026-03-18 3/150 2026-03-21 00:39 by JourneyLucky
[考研] 材料专业求调剂 +6 hanamiko 2026-03-18 6/300 2026-03-21 00:24 by JourneyLucky
[考研] 22408 344分 求调剂 一志愿 华电计算机技术 +4 solanXXX 2026-03-20 4/200 2026-03-20 23:49 by alg094825
[考研] 一志愿苏州大学材料求调剂,总分315(英一) +5 sbdksD 2026-03-19 5/250 2026-03-20 22:10 by luoyongfeng
[考研] 295复试调剂 +8 简木ChuFront 2026-03-19 8/400 2026-03-20 20:44 by zhukairuo
[考研] 295材料求调剂,一志愿武汉理工085601专硕 +5 Charlieyq 2026-03-19 5/250 2026-03-20 20:35 by JourneyLucky
[考研] 一志愿吉林大学材料学硕321求调剂 +11 Ymlll 2026-03-18 15/750 2026-03-20 19:40 by 丁丁*
[考研] 085600材料与化工调剂 324分 +10 llllkkkhh 2026-03-18 12/600 2026-03-19 14:33 by llllkkkhh
[考研] 328求调剂,英语六级551,有科研经历 +4 生物工程调剂 2026-03-16 12/600 2026-03-19 11:10 by 生物工程调剂
[考研] 344求调剂 +6 knight344 2026-03-16 7/350 2026-03-18 20:13 by walc
[考研] 【同济软件】软件(085405)考研求调剂 +3 2026eternal 2026-03-18 3/150 2026-03-18 19:09 by 搏击518
[考研] 化学工程321分求调剂 +15 大米饭! 2026-03-15 18/900 2026-03-18 14:52 by haxia
[论文投稿] 有没有大佬发小论文能带我个二作 +3 增锐漏人 2026-03-17 4/200 2026-03-17 09:26 by xs74101122
[考研] 333求调剂 +3 文思客 2026-03-16 7/350 2026-03-16 18:21 by 文思客
[考研] 304求调剂 +4 ahbd 2026-03-14 4/200 2026-03-16 16:48 by 我的船我的海
[考研] 318求调剂 +3 Yanyali 2026-03-15 3/150 2026-03-16 16:41 by houyaoxu
[考研] 0703化学调剂 290分有科研经历,论文在投 +7 腻腻gk 2026-03-14 7/350 2026-03-16 10:12 by houyaoxu
[考研] 0856求调剂 +3 刘梦微 2026-03-15 3/150 2026-03-16 10:00 by houyaoxu
[考研] 中科大材料与化工319求调剂 +3 孟鑫材料 2026-03-14 3/150 2026-03-14 20:10 by ms629
信息提示
请填处理意见